Microsoft Stock Outlook, Azure & AI as Drivers of Long-Term Growth
Microsoft (NASDAQ:MSFT) has been among the top growth stocks of…
Sell
35
RXRX Quote, Financials, Valuation and Earnings
Last price:
$4.40
Seasonality move
:
16.58%
Day range:
$4.38 - $4.69
52-week range:
$3.79 - $12.36
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
23.22x
P/B ratio:
1.91x
Volume:
23.3M
Avg. volume:
18.7M
1-year change:
-51.11%
Market cap:
$1.8B
Revenue:
$58.5M
EPS (TTM):
-$1.77
Earnings Data
Next earnings date for RXRX
Aug 08
2025
Most recent earnings per share
-$0.50
Beat by $0.02
(May 5/2025)
Consensus Estimate
-$0.52
(May 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RXRX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/08/2025 | Q2 | $16.2M | -- | -- | -$0.36 | -- |
| 05/05/2025 | Q1 | $18.1M | $14.8M | -$0.50 | -$0.52 | $0.02 |
| 02/28/2025 | Q4 | $19M | $4.5M | -$0.53 | -$0.42 | -$0.11 |
| 11/06/2024 | Q3 | $29.8M | $26.1M | -$0.34 | -$0.33 | -$0.01 |
| 08/08/2024 | Q2 | $13.3M | $14.4M | -$0.40 | -$0.38 | -$0.02 |
| 05/09/2024 | Q1 | $13.1M | $13.5M | -$0.39 | -$0.43 | $0.04 |
| 02/27/2024 | Q4 | $20.4M | $10.6M | -$0.42 | -$0.45 | $0.03 |
| 11/09/2023 | Q3 | -- | -- | -$0.43 | -$0.39 | -$0.04 |
| 08/08/2023 | Q2 | -- | -- | -$0.38 | -$0.37 | -$0.01 |
| 05/08/2023 | Q1 | -- | -- | -$0.34 | -$0.35 | $0.01 |
| 02/27/2023 | Q4 | -- | -- | -$0.31 | -$0.24 | -$0.07 |
| 11/08/2022 | Q3 | -- | -- | -$0.35 | -$0.38 | $0.03 |
| 08/09/2022 | Q2 | -- | -- | -$0.38 | -$0.37 | -$0.01 |
| 05/10/2022 | Q1 | -- | -- | -$0.33 | $0.51 | -$0.84 |
| 03/23/2022 | Q4 | -- | -- | -$0.38 | -$0.31 | -$0.07 |
| 11/10/2021 | Q3 | -- | -- | -$0.28 | -$0.28 | $0.00 |
| 08/13/2021 | Q2 | -- | -- | -$0.31 | -$0.24 | -$0.07 |
| 03/31/2021 | Q1 | -- | -- | -$0.20 | -$0.23 | $0.04 |
| 12/31/2020 | Q4 | -- | -- | -$0.23 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.17 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.16 | -- | -- |
Recursion Pharmaceuticals Earnings Questions
-
How Much did Recursion Pharmaceuticals Generate in Revenue Last Quarter?
Recursion Pharmaceuticals reported $14.8M worth of top line sales in its most recent quarter.
-
Did Recursion Pharmaceuticals Beat Earnings Last Quarter?
Recursion Pharmaceuticals announced earnings per share of -$0.50 which represents a beat of analyst forecast a -$0.52 per share.
-
Is Recursion Pharmaceuticals Profitable?
Recursion Pharmaceuticals reported -$7M that represents -$0.02 per share over the last quarter.
-
What is the Analyst Consensus for Recursion Pharmaceuticals EPS Next Year?
Recursion Pharmaceuticals's earnings are forecast to decrease from -$1.69 per share to -$1.54 per share next year representing a decrease of -13.74%.
-
When is Recursion Pharmaceuticals's Earnings Date?
Recursion Pharmaceuticals's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Stock Overvalued or a Buy for the Next Decade?
Shares of EV major Tesla (NASDAQ:TSLA) have experienced extreme volatility…
Is Apple Stock Undervalued or Overvalued?
For many years, Apple (NASDAQ:AAPL) was just about the perfect…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
68
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
80
SBET alert for May 29
SharpLink Gaming [SBET] is up 48.29% over the past day.
Buy
100
BOX alert for May 29
Box [BOX] is down 0.57% over the past day.
Sell
22
OKTA alert for May 29
Okta [OKTA] is up 1.32% over the past day.
